Healthcare provider profile · identity verified

Daniel Eric Wollman, M.D, PHD

Geriatric Medicine · SHELTON, CT · NPI 1659344596

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	438	52
Atorvastatin Calcium	Atorvastatin Calcium	435	89
Trazodone Hcl	Trazodone Hcl	372	64
Furosemide	Furosemide	341	69
Levothyroxine Sodium	Levothyroxine Sodium	333	61
Escitalopram Oxalate	Escitalopram Oxalate	313	59
Mirtazapine	Mirtazapine	282	53
Amlodipine Besylate	Amlodipine Besylate	271	59
Gabapentin	Gabapentin	226	37
Metoprolol Tartrate	Metoprolol Tartrate	222	50
Pantoprazole Sodium	Pantoprazole Sodium	219	48
Losartan Potassium	Losartan Potassium	213	42
Metoprolol Succinate	Metoprolol Succinate	179	42
Omeprazole	Omeprazole	162	33
Lisinopril	Lisinopril	130	23
Xarelto	Rivaroxaban	117	16
Risperidone	Risperidone	116	22
Rosuvastatin Calcium	Rosuvastatin Calcium	114	27
Sertraline Hcl	Sertraline Hcl	103	21
Januvia	Sitagliptin Phosphate	102	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	102	16
Carvedilol	Carvedilol	93	17
Ondansetron Hcl	Ondansetron Hcl	93	39
Clopidogrel	Clopidogrel Bisulfate	90	20
Duloxetine Hcl	Duloxetine Hcl	90	15
Myrbetriq	Mirabegron	84	11
Metformin Hcl	Metformin Hcl	77	20
Tamsulosin Hcl	Tamsulosin Hcl	75	16
Latanoprost	Latanoprost	73	18
Oxycodone Hcl	Oxycodone Hcl	71	suppressed
Potassium Chloride	Potassium Chloride	70	13
Tradjenta	Linagliptin	66	suppressed
Amiodarone Hcl	Amiodarone Hcl	63	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	63	12
Allopurinol	Allopurinol	62	12
Pravastatin Sodium	Pravastatin Sodium	60	11
Tramadol Hcl	Tramadol Hcl	58	25
Donepezil Hcl	Donepezil Hcl	55	11
Prednisone	Prednisone	55	17
Baclofen	Baclofen	54	suppressed
Cephalexin	Cephalexin	53	28
Famotidine	Famotidine	53	14
Jardiance	Empagliflozin	53	suppressed
Levetiracetam	Levetiracetam	49	suppressed
Entresto	Sacubitril/Valsartan	47	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	45	suppressed
Ezetimibe	Ezetimibe	44	suppressed
Memantine Hcl	Memantine Hcl	44	11
Lorazepam	Lorazepam	43	15
Labetalol Hcl	Labetalol Hcl	41	suppressed
Simvastatin	Simvastatin	41	12
Warfarin Sodium	Warfarin Sodium	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	14
Finasteride	Finasteride	31	suppressed
Valsartan	Valsartan	31	suppressed
Albuterol Sulfate	Albuterol Sulfate	30	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	15
Methocarbamol	Methocarbamol	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Phenobarbital	Phenobarbital	26	suppressed
Lactulose	Lactulose	25	suppressed
Methenamine Hippurate	Methenamine Hippurate	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Ketoconazole	Ketoconazole	21	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Levofloxacin	Levofloxacin	20	11
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Restasis	Cyclosporine	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Clonidine	Clonidine	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Primidone	Primidone	16	suppressed
Torsemide	Torsemide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Mirabegron Er	Mirabegron	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nitroglycerin Patch	Nitroglycerin	14	suppressed
Ramipril	Ramipril	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	11	suppressed
Alprazolam	Alprazolam	11	suppressed
Atenolol	Atenolol	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error